Sanofi

Media Room

Julia Schwendner, Process Responsible Scientist, smiling in a green lab coat, hairnet and safety goggles while standing in front of industrial bioprocessing equipment at Sanofi's Frankfurt facility.

Third Quarter 2025

Third quarter 2025 results will be reviewed by management during a live audio webcast with the financial community on October 24, 2025. The presentation will be followed by a Q&A session.

Press releases


September 24, 2025
Press Release: Sanofi commits an additional $625 million to Sanofi Ventures to accelerate investment in biotech and digital health innovation

September 24, 2025
Press release: Availability of the Q3 2025 Aide mémoire

September 23, 2025
Press Release: Sanofi’s SAR446268 earns US fast track designation for the treatment of non-congenital myotonic dystrophy type 1

Contact Our Media Team

You are a journalist and have a question about Sanofi, please contact the Global Media relations team. Please note the contact details are only for journalists.

Publications

Half year 2025 financial report XBRL package
Download PDF
Half Year 2025 Financial Report
Download PDF
Sustainability Statement 2024 (ESG Report)
Download PDF
Registration Document 2024 (in French)
Download PDF